MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Three-Year Results from the Largest Prospective Cohort of Directional Subthalamic Deep Brain Stimulation in Parkinson’s Disease to Date

    G. Deuschl, M. Barbe, S. Paschen, A. Kühn, C. Sik Lee, J. Volkmann, J. Vesper, R. Shivacharan, E. Goldberg (Kiel, Germany)

    Objective: To evaluate long-term real-world motor, quality-of-life, medication, and safety outcomes in patients with Parkinson’s disease (PD) treated with a multiple-independent-current-control (MICC) directional deep brain…
  • 2026 International Congress

    High Step Marching Dyskinesia: A Case Series

    N. Pulley, I. Bledsoe, P. Hoang (San Francisco, USA)

    Objective: To describe high step marching dyskinesia in two patients with Parkinson's disease (PD) Background: Levodopa-induced dyskinesias can interfere with gait in patients with Parkinson’s…
  • 2026 International Congress

    Methamphetamine: An Underrecognized Cause of Acute Chorea – A Case Report and Literature Review

    C. Kanchanawuttitham, J. Jitprapaikulsan, YP. Pitakpatapee (Bangkok, Thailand)

    Objective: To report a case of methamphetamine-induced choreoathetosis and review the literature regarding its clinical features, related phenomenology, and treatment response. Background: Acute onset of…
  • 2026 International Congress

    Holistic Sensor-Based Profiling of Parkinson’s Disease via Mixed Reality: Implementation and Multimodal Feasibility

    W. Szecowka, M. Wojcik-Pedziwiatr, M. Baran, J. Stepien, P. Jemiolo, N. Bozetine, M. Dudek, J. Krzywdziak, M. Zbik, D. Hemmerling, M. Rudzynska-Bar (Kraków, Poland)

    Objective: To validate a novel multimodal mixed-reality (MR) platform utilizing HoloLens 2 for the automated assessment of Parkinson’s disease (PD) symptoms and to determine the…
  • 2026 International Congress

    Parkinsonism in B-Cell Maturation Antigen-Targeting CAR-T Cell Cancer Therapies

    A. Zolin, V. Gao, D. Riegel, C. Snajdr-Trinch, B. Santomasso, R. Magge, S. Wesley, H. Danish, H. Sarva, H. Ooi, A. Yoo (New York, USA)

    Objective: Describe parkinsonism after B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T-cell therapy for treatment of multiple myeloma. Background: BCMA-targeted CART-cell therapy effectively treats…
  • 2026 International Congress

    Phenotypic Evolution from Nonfluent PPA to PSP

    S. Park (Sejong-si, Republic of Korea)

    Objective: Progressive Supranuclear Palsy (PSP) and Nonfluent Primary Progressive Aphasia (nfvPPA) are clinicopathological entities within the 4-repeat tauopathy (4R tauopathy) spectrum. Increasing evidence suggests that…
  • 2026 International Congress

    Wearable-Derived Cardiac Features and Cardiac–Motor Interconnection Across Parkinson’s Disease Severities

    P. Arrue (Santiago, Chile)

    Objective: To examine how wearable-derived cardiac performance and cardiac–motor interconnection (CCM) vary across Parkinson’s disease (PD) severities, stratified by the Parkinson’s disease–cognitive rating scale (PD-CRS)…
  • 2026 International Congress

    A Deep Learning Model-based Screening System for Nystagmus in Central Vertigo

    H. Takeda, K. Eguchi, S. Shirai, H. Yaguchi, K. Fujiwara, I. Yabe (Sapporo, Japan)

    Objective: We aimed to classify nystagmus videos into central and peripheral nystagmus using a deep learning model. Background: Diverse causes underlie vertigo, and while clinically…
  • 2026 International Congress

    Longitudinal Weight/BMI Trajectories and Their Clinical Impact on Parkinson’s Disease.

    K. Sánchez-Ramírez, N. Sánchez-Lorenzo, A. Beltrán-Torres, M. Rocha-de-León, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate longitudinal weight/BMI trajectory classes in PwP and their association with motor progression and quality of life (QoL). Background: Weight homeostasis is frequently…
  • 2026 International Congress

    Baseline plasma neurofilament light and phosphorylated tau 181 levels predict longitudinal cognitive decline in APOE4 and long SNCA Rep1 carriers in Parkinson’s disease

    S. Ng, J. Tan, E. Saffari, E. Ng, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan, A. Ng (Singapore, Singapore)

    Objective: Plasma neurofilament light (NfL; a marker of axonal injury) and phosphorylated tau 181 (pTau181) are biomarkers that have been associated with cognitive decline in…
  • « Previous Page
  • 1
  • …
  • 169
  • 170
  • 171
  • 172
  • 173
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley